New pill combo aims to boost cancer fight in tough cases

NCT ID NCT07287917

Summary

This study is testing whether adding two new oral drugs, AMXT 1501 and DFMO, to standard cancer treatments can help control advanced breast cancer or melanoma that has continued to grow despite prior therapies. The trial will first find a safe dose and then see how well the combination works to shrink tumors or stop their growth. It is for adults whose cancer has spread and is no longer responding to available treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Laguna Clinical Research Associates

    RECRUITING

    Laredo, Texas, 78041, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lumi Research

    RECRUITING

    Houston, Texas, 77090, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START Cancer Research New York-Long Island

    RECRUITING

    Lake Success, New York, 11042, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START Los Angeles

    RECRUITING

    Los Angeles, California, 90025, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START Mountain Region

    RECRUITING

    West Valley City, Utah, 84119, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Texas-MD Anderson

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Wisconsin-Madison Carbone Cancer Center

    RECRUITING

    Madison, Wisconsin, 53706, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Virginia Cancer Specialists-Fairfax

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.